ConductScience.org, home

Paper30736766

Large-scale production of tauroursodeoxycholic acid products through fermentation optimization of engineered Escherichia coli cell factory.

Xu Y and 3 others. Microb Cell Fact, 2019. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Large-scale production of tauroursodeoxycholic acid products through fermentation optimization of engineered Escherichia coli cell factory. Papers, record 30736766. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30736766

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Large-scale production of tauroursodeoxycholic acid products through fermentation optimization of engineered Escherichia coli cell factory.
PubMed
Journal
Microb Cell Fact
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.91
iCite
Revised in PubMed
2020-12-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xu YYingpeng
2Yang LLi
3Zhao SShujuanhttps://orcid.org/0000-0002-2269-925X
4Wang ZZhengtao

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Escherichia coliMajor topic
Taurochenodeoxycholic AcidMajor topic
Bioreactors
Biotransformation
Fermentation
Glycerol
Industrial Microbiology

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2017ZX09309006National Science and Technology (S&T) Major Special ProjectsPubMed
81673540National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116944129Growth of E. coli BL21 in minimal media with different gluconeogenic carbon sources and salt contents.Appl Microbiol Biotechnol2007https://conductscience.org/library/papers/16944129PubMed
217938905Standardized biosynthesis of flavan-3-ols with effects on pancreatic beta-cell insulin secretion.Appl Microbiol Biotechnol2007https://conductscience.org/library/papers/17938905PubMed
318488143Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics.Cell Mol Life Sci2008https://conductscience.org/library/papers/18488143PubMed
418600786Improvement of xylanase production by Aspergillus niger XY-1 using response surface methodology for optimizing the medium composition.J Zhejiang Univ Sci B2008https://conductscience.org/library/papers/18600786PubMed
518772282Progress in metabolic engineering of Saccharomyces cerevisiae.Microbiol Mol Biol Rev2008https://conductscience.org/library/papers/18772282PubMed
619053324Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry.Chem Res Toxicol2008https://conductscience.org/library/papers/19053324PubMed
719138420Bear bile: dilemma of traditional medicinal use and animal protection.J Ethnobiol Ethnomed2009https://conductscience.org/library/papers/19138420PubMed
819356927Medium optimization for the production of avermectin B1a by Streptomyces avermitilis 14-12A using response surface methodology.Bioresour Technol2009https://conductscience.org/library/papers/19356927PubMed
919648908Synthetic protein scaffolds provide modular control over metabolic flux.Nat Biotechnol2009https://conductscience.org/library/papers/19648908PubMed
1021599905Metabolic regulation of Escherichia coli and its phoB and phoR genes knockout mutants under phosphate and nitrogen limitations as well as at acidic condition.Microb Cell Fact2011https://conductscience.org/library/papers/21599905PubMed
1122151908The impact of phosphate scarcity on pharmaceutical protein production in S. cerevisiae: linking transcriptomic insights to phenotypic responses.Microb Cell Fact2011https://conductscience.org/library/papers/22151908PubMed
1222198717In search of sustainable chemical processes: cloning, recombinant expression, and functional characterization of the 7α- and 7β-hydroxysteroid dehydrogenases from Clostridium absonum.Appl Microbiol Biotechnol2012https://conductscience.org/library/papers/22198717PubMed
1322316556New fluorescent bile acids: synthesis, chemical characterization, and disastereoselective uptake by Caco-2 cells of 3-deoxy 3-NBD-amino deoxycholic and ursodeoxycholic acid.Bioorg Med Chem2012https://conductscience.org/library/papers/22316556PubMed
1422566191Production of miltiradiene by metabolically engineered Saccharomyces cerevisiae.Biotechnol Bioeng2012https://conductscience.org/library/papers/22566191PubMed
1522581067Novel whole-cell biocatalysts with recombinant hydroxysteroid dehydrogenases for the asymmetric reduction of dehydrocholic acid.Appl Microbiol Biotechnol2012https://conductscience.org/library/papers/22581067PubMed
1622899496One-step synthesis of 12-ketoursodeoxycholic acid from dehydrocholic acid using a multienzymatic system.Appl Microbiol Biotechnol2013https://conductscience.org/library/papers/22899496PubMed
1723203100Optimization of lipase production by Burkholderia sp. using response surface methodology.Int J Mol Sci2012https://conductscience.org/library/papers/23203100PubMed
1823640741Synthesis and evaluation of water-soluble prodrugs of ursodeoxycholic acid (UDCA), an anti-apoptotic bile acid.ChemMedChem2013https://conductscience.org/library/papers/23640741PubMed
1923729502Contribution of the 7β-hydroxysteroid dehydrogenase from Ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon.J Lipid Res2013https://conductscience.org/library/papers/23729502PubMed
2024495798Application of response surface methodology and artificial neural network methods in modelling and optimization of biosorption process.Bioresour Technol2014https://conductscience.org/library/papers/24495798PubMed

See all 40 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
41039607Biosynthesis of tauro-ursodeoxycholic acid (TUDCA) in Saccharomyces cerevisiae.Microb Cell Fact2025https://conductscience.org/library/papers/41039607PubMed
40999182High-level production of Tauroursodeoxycholic acid from Taurochenodeoxycholic acid in engineered Bacillus subtilis via whole-cell biotransformation.World J Microbiol Biotechnol2025https://conductscience.org/library/papers/40999182PubMed
39931379Cost-effective whole-cell biosynthesis of ursodeoxycholic acid using engineered Escherichia coli with a multienzyme cascade.Front Microbiol2025https://conductscience.org/library/papers/39931379PubMed
39623449Synthesis of TUDCA from chicken bile: immobilized dual-enzymatic system for producing artificial bear bile substitute.Microb Cell Fact2024https://conductscience.org/library/papers/39623449PubMed
38647767A green strategy to produce potential substitute resource for bear bile using engineered Saccharomyces cerevisiae.Bioresour Bioprocess2022https://conductscience.org/library/papers/38647767PubMed
37738435Metabolic engineering and optimization of Escherichia coli co-culture for the de novo synthesis of genkwanin.J Ind Microbiol Biotechnol2023https://conductscience.org/library/papers/37738435PubMed
36910199Biological synthesis of ursodeoxycholic acid.Front Microbiol2023https://conductscience.org/library/papers/36910199PubMed
36329440Tailoring and optimizing fatty acid production by oleaginous yeasts through the systematic exploration of their physiological fitness.Microb Cell Fact2022https://conductscience.org/library/papers/36329440PubMed
31757001Tauroursodeoxycholate-Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives.Cells2019https://conductscience.org/library/papers/31757001PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30736766

GET https://conductscience.org/api/papers/v1/30736766/references?page=2